Alternative non-hormonal methods for correcting menopausal disorders

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. Systematic analysis of the data available in modern literature on the possibilities of non-hormonal correction of menopausal syndrome.

Basic provisions. Menopausal syndrome is characterized by a symptom complex that includes vegetative-vascular, mental and metabolic-endocrine disorders as result of a single pathogenetic process caused by estrogen deficiency and subsequent dysfunction of the hypothalamic-pituitary system. If there are contraindications and concerns about the safety of the use of menopausal hormone therapy, it is possible to use alternative non-hormonal agents to relieve the symptoms of menopausal syndrome.

Conclusion. Based on the analysis of literary sources, modern data regarding current methods of non-hormonal correction of menopausal disorders in women during peri- and postmenopause were summarized.

Full Text

Restricted Access

About the authors

Dayana A. Boris

National Medical Research Center for Obstetrics, Gynecology and Perinatology n.a. Academician V.I. Kulakov

Author for correspondence.
Email: dayana_boris@mail.ru
ORCID iD: 0000-0002-0387-4040
SPIN-code: 4832-0643

Cand. Sci. (Med.), Obstetrician-Gynecologist, Ultrasound Specialist, Researcher at the Department of Aesthetic Gynecology and Rehabilitation

Russian Federation, Moscow

I. A. Apolikhina

National Medical Research Center for Obstetrics, Gynecology and Perinatology n.a. Academician V.I. Kulakov

Email: dayana_boris@mail.ru
ORCID iD: 0000-0002-4581-6295
SPIN-code: 6282-7435
Russian Federation, Moscow

L. A. Tarnaeva

National Medical Research Center for Obstetrics, Gynecology and Perinatology n.a. Academician V.I. Kulakov

Email: dayana_boris@mail.ru
ORCID iD: 0009-0006-7500-7516
Russian Federation, Moscow

References

  1. Davis S.R., Pinkerton J., Santoro N., Simoncini T. Menopause-Biology, consequences, sup-portive care, and therapeutic options. Cell. 2023;186(19):4038-4058. doi: 10.1016/j.cell.2023.08.016.
  2. Mohebbi R., Shojaa M., Kohl M., et al. Exercise training and bone mineral density in postmenopausal women: an updated systematic review and meta-analysis of intervention studies with emphasis on potential moderators. Osteoporos Int. 2023 Jul;34(7):1145–1178. doi: 10.1007/s00198-023-06682-1.
  3. Юренева С.В., Аверкова В.Г. Вазомоторные симптомы в менопаузе: центральные триггеры, эффекторы и новые возможности патогенетической терапии. Российский вестник акушера-гинеколога. 2018;18(5):43 48. [Yureneva S.V., Averkova V.G. Menopausal vasomotor symptoms: central triggers, effectors, and new possibilities of pathogenetic therapy. Russian Bulletin of Obstetrician-Gynecologist. 2018;18(5):43-48. (In Russ.)]. doi: 10.17116/rosakush20181805143.
  4. Kingsberg S.A., Schulze-Rath R., Mulligan C., et al. Global view of vasomotor symptoms and sleep disturbance in menopause: a systematic review. Climacteric. 2023 Dec;26(6):537–549. doi: 10.1080/13697137.2023. 2256658.
  5. Gatenby C., Simpson P. Menopause: Physiology, definitions, and symptoms. Best Pract Res Clin Endocrinol Metab. 2024 Jan;38(1):101855. doi: 10.1016/j.beem.2023.101855.
  6. Сухих Г.Т., Сметник В.П., Андреева Е.Н. и др. Менопаузальная гормонотерапия и сохранение здоровья женщин в зрелом возрасте. Клинические рекомендации. 2015, P. 8–9. [Sukhikh G.T., Smetnik V.P., Andreeva E.N., et al. Menopausal hormone therapy and maintaining women’s health in adulthood. Clinical guidelines. 2015, P. 8–9. (In Russ.)].
  7. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause. 2020;27(9):976–992. doi: 10.1097/GME.0000000000001609.
  8. Baber R.J., Panay N., Fenton A. 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy. Climacteric. 2016;19(2):109–150. doi: 10.3109/13697137.2015.1129166.
  9. Клинические рекомендации «Менопауза и климактерическое состояние у женщины», 2021. [Clinical guidelines “Menopause and climacteric state in women”, 2021. (In Russ.)]. URL: https://cr.minzdrav.gov.ru/schema/117_2; https://roag-portal.ru/recommendations_gynecology
  10. Coronado P.J., Gomez A., Iglesias E., et al.; HMT Eligibility Criteria Group. Eligibility criteria for using menopausal hormone therapy in breast cancer survivors: a safety report based on a systematic review and meta-analysis. Menopause. 2024 Mar 1;31(3):234–242. doi: 10.1097/GME.0000000000002317.
  11. Canivenc-Lavier M.C., Bennetau-Pelissero C. Phytoestrogens and Health Effects. Nutrients. 2023 Jan 9;15(2):317. doi: 10.3390/nu15020317.
  12. Mosselman S., Polman J., Dijkema R. ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett. 1996;392:49–53.
  13. Brzezinski A., Debi A. Phytoestrogens: the ‘natural’ selective estrogen receptor modulators? Eur J Obstet Gynecol Reprod Biol. 1999;85:47–51.
  14. Patra S., Gorai S., Pal S., et al. A review on phytoestrogens: Current status and future direction. Phytother Res. 2023 Jul;37(7):3097-3120. doi: 10.1002/ptr.7861.
  15. Corbi G., Nobile V., Conti V., et al. Equol and Resveratrol Improve Bone Turnover Biomarkers in Postmenopausal Women: A Clinical Trial. Int J Mol Sci. 2023 Jul 27;24(15):12063. doi: 10.3390/ijms241512063.
  16. Taku K., Melby M.K., Kronenberg F., et al. Extracted or synthesized soybean isoflavones reduce menopausal hot flash frequency and severity: systematic review and meta-analysis of randomized controlled trials. Menopause. 2012 Jul;19(7):776–90. doi: 10.1097/gme.0b013e3182410159.
  17. Cheng P.F., Chen J.J., Zhou X.Y., et al. Do soy isoflavones improve cognitive function in postmenopausal women? A meta-analysis. Menopause. 2015 Feb;22(2):198–206. doi: 10.1097/GME.0000000000000290.
  18. Филиппова О.В. Фитоэстрогены: перспективы применения. Эффективная фармакотерапия. 2020;16(22):30–36. [Filippova O.V. Phytoestrogens: application prospects. Effektivnaya farmakoterapiya=Effective pharmacotherapy. 2020;16(22):30–36. (In Russ.)]. doi: 10.33978/2307-3586-2020-16-22-30-36.
  19. Ghazanfarpour M., Sadeghi R., Latifnejad Roudsari R., et al. Effects of red clover on hot flash and circulating hormone concentrations in menopausal women: a systematic review and meta-analysis. Avicenna J Phytomed. 2015 Nov-Dec;5(6):498–511.
  20. Myers S.P., Vigar V. Effects of a standardised extract of Trifolium pratense (Promensil) at a dosage of 80mg in the treatment of menopausal hot flushes: A systematic review and meta-analysis. Phytomedicine. 2017 Jan 15;24:141-147. doi: 10.1016/j.phymed.2016.12.003.
  21. Mason J.K., Thompson L.U. Flaxseed and its lignan and oil components: can they play a role in reducing the risk of and improving the treatment of breast cancer? Appl Physiol Nutr Metab. 2014 Jun;39(6):663–78. doi: 10.1139/apnm- 2013-0420.
  22. Di Y., De Silva F., Krol E.S., Alcorn J. Flaxseed Lignans Enhance the Cytotoxicity of Chemotherapeutic Agents against Breast Cancer Cell Lines MDA-MB-231 and SKBR3. Nutr Cancer. 2018 Feb-Mar;70(2):306–315. doi: 10.1080/01635581.2018.1421677.
  23. Flower G., Fritz H., Balneaves L.G., et al. Flax and Breast Cancer: A Systematic Review. Integr Cancer Ther. 2014 May;13(3):181–92. doi: 10.1177/1534735413502076.
  24. Мартинчик А.Н., Зубцов В.В. Фитоэстрогенные свойства лигнанов семян льна. Вопросы питания. 2012;81(6):61–6. [Martinchik A.N., Zubtsov V.V. Phytoestrogenis properties of flaxseed lignans. Voprosy Pitaniya. 2012;81(6):61–6. (In Russ.)].
  25. Das M., Das D.K. Resveratrol and cardiovascular health. Mol Aspects Med. 2010 Dec;31(6):503–12. doi: 10.1016/j.mam.2010.09.001.
  26. Thaung Zaw J.J., Howe P.R., Wong R.H. Long-term effects of resveratrol on cognition, cerebrovascular function and cardio-metabolic markers in postmenopausal women: A 24-month randomised, double-blind, placebo-controlled, crossover study. Clin Nutr. 2021 Mar;40(3):820–829. doi: 10.1016/j.clnu.2020.08.025.
  27. Tu W., Song M., Fan X. Does resveratrol improve cognition in humans? A scientometric study to an in-depth review. CNS Neurosci Ther. 2023 Sep;29(9):2413–2429. doi: 10.1111/cns.14276.
  28. Wong R.H., Thaung Zaw J.J., Xian C.J., Howe P.R. Regular Supplementation With Resveratrol Improves Bone Mineral Density in Postmenopausal Women: A Randomized, Placebo-Controlled Trial. J Bone Miner Res. 2020 Nov;35(11):2121–2131. doi: 10.1002/jbmr.4115.
  29. Menopause. Biology and pathobiology. Eds. R.A. Lobo, J. Kelsey, R. Marcus. Academic Рress, 2000. 657 p.
  30. Phillips B., Collop N., Drake C., et al. Sleep disorders and medical conditions in women; Proceedings of the women & sleep workshop, national sleep foundation; Washington, DC. March 5–6, 2007; J Womens Health (Larchmt). 2008; 17:1191–9.
  31. Kessler R., McGonagle K., Swartz M., et al. Sex and depression in the National Comorbidity Survey I: lifetime prevalence, chronicity and recurrence. J Affect Disord. 1993:2–3:85–96.
  32. Mitchell S.E., Woods F.N. Midlife women’s attributions about perceived memory changes: observations from the Seattle Midlife Women’s Health Study. J Women Health Gend Based Med. 2001;10:351–62.
  33. Betti S., Orsini M.R., Sciaky R., et al. Attitudes towards menopause in a group of women followed in a public service for menopause counseling. Aging. 2001;13:331–8.
  34. Javelle F., Lampit A., Bloch W., et al. Effects of 5-hydroxytryptophan on distinct types of depression: a systematic review and meta-analysis. Nutr Rev. 2020 Jan 1;78(1):77–88. doi: 10.1093/nutrit/nuz039.
  35. Cangiano C., Ceci F., Cascino A., et al. Eating behavior and adherence to dietary prescriptions in obese adult subjects treated with 5-hydroxytryptophan. Am J Clin Nutr. 1992 Nov;56(5):863–7. doi: 10.1093/ajcn/ 56.5.863.
  36. Овсянникова Т.В., Макаров И.О., Куликов И.А. Клиническая эффективность негормональных методов терапии у женщин в перименопаузе. Акушерство, гинекология, репродукция. 2013;7(3):26–9. [Ovsyannikova T.V., Maka-rov I.O., Kulikov I.A. Clinical efficacy of non-hormonal therapy methods in perimenopausal women. Akusherstvo, ginekologiya, reproduktsiya=Obstetrics, Gynecology and Reproduction. 2013;7(3):26–9. (In Russ.)].

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies